Package 51672-4042-3

{"route": ["ORAL"], "spl_id": "22e382fc-edce-24b7-e063-6394a90a35e6", "openfda": {"upc": ["0351672404314"], "unii": ["63FN7G03XY"], "rxcui": ["197464", "197465", "197466"], "spl_set_id": ["499a6989-8912-44b7-b1eb-ee8f85ae378f"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (51672-4042-1)", "package_ndc": "51672-4042-1", "marketing_start_date": "20000427"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (51672-4042-2)", "package_ndc": "51672-4042-2", "marketing_start_date": "20000427"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (51672-4042-3)", "package_ndc": "51672-4042-3", "marketing_start_date": "20000427"}], "brand_name": "Clorazepate Dipotassium", "product_id": "51672-4042_22e382fc-edce-24b7-e063-6394a90a35e6", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "51672-4042", "dea_schedule": "CIV", "generic_name": "Clorazepate Dipotassium", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clorazepate Dipotassium", "active_ingredients": [{"name": "CLORAZEPATE DIPOTASSIUM", "strength": "3.75 mg/1"}], "application_number": "ANDA075731", "marketing_category": "ANDA", "marketing_start_date": "20000427", "listing_expiration_date": "20261231"}